Horizon Therapeutics
1 Horizon Way
Deerfield
IL
60015
United States
650 articles about Horizon Therapeutics
-
ISS And Glass Lewis Recommend Horizon Pharma Shareholders Vote AGAINST The Issuance Of Horizon Shares In Connection With Horizon's Attempted Takeover Of Depomed
11/4/2015
-
Horizon Pharma To Host Investor Day On November 9, 2015
11/3/2015
-
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering VIMOVO (Naproxen/Esomeprazole) Delayed Release Tablets
10/28/2015
-
Horizon Pharma Extends Offer to Acquire Depomed
10/27/2015
-
Horizon Pharma Corrects Misinformation In The Marketplace
10/27/2015
-
Horizon Pharma Provides Update on Relationship With Specialty Pharmacies
10/22/2015
-
Horizon Pharma Fires Back at the New York Times Report on Prescriptions Made Easy Practice
10/22/2015
-
Horizon Pharma Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering PENNSAID (diclofenac sodium topical solution) 2%
10/22/2015
-
Depomed Comments On Recent Reports Regarding Horizon Pharma's Business Model
10/22/2015
-
Horizon Pharma Announces Favorable Markman Ruling in RAVICTI (glycerol phenylbutyrate) Oral Liquid Patent Infringement Lawsuit
10/21/2015
-
Horizon Pharma To Host Third Quarter 2015 Conference Call And Webcast On November 6, 2015
10/20/2015
-
Horizon Pharma plc Release: Files Definitive Proxy Statement For Extraordinary General Meeting Of Horizon Pharma Shareholders
10/15/2015
-
Horizon Pharma plc Files Definitive Proxy Statement For Extraordinary General Meeting Of Horizon Pharma Shareholders
10/15/2015
-
Horizon Pharma Files Preliminary Proxy Materials For Special Meetings
10/14/2015
-
Horizon Pharma Chairman And Chief Executive Officer Timothy P. Walbert Inducted Into Chicago Area Entrepreneurship Hall Of Fame At UIC Institute For Entrepreneurial Studies
10/13/2015
-
Horizon Pharma Announces That Three Of The Leading Proxy Advisory Firms Recommend That Depomed Shareholders Provide Consent For The Special Meetings Requests
10/8/2015
-
Amidst Hostile Takeover Attempt of Depomed, Horizon Pharma Triples Size of U.S. Headquarters
10/6/2015
-
Horizon Pharma Announces Settlement Of RAYOS(R) (prednisone) Delayed-Release Tablets Patent Litigation With Actavis Laboratories FL Inc.
10/2/2015
-
Horizon Pharma Announces Leading Proxy Advisory Service, Glass Lewis & Co., Recommends Depomed Shareholders Provide Consent FOR The Two Special Meeting Requests
9/30/2015
-
Horizon Pharma Receives Positive CHMP Opinion For RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For The Treatment Of Urea Cycle Disorders In Patients Greater Than Two Months Of Age
9/29/2015